This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 439acdf0-e973-4109-bf89-fd194ae9
Heart attacks and strokes — the leading causes of death in human beings — are fundamentally blood clots of the heart and brain. Better understanding how the blood-clotting process works
Credit: Anna Shvets from Pexels Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a study published online Sept. 9 in Circulation: Heart
